Press release
B-Aware to prevent good times turning bad
PRESS RELEASE: Intended for distribution to Indian and Pakistani UK-based media and UK medical trade media onlyB-Aware to prevent good times turning bad
11 September 2013
Ahead of Hajj pilgrimage, GSK launches ‘B-Aware’ – Hepatitis B awareness campaign to help educate and tackle misconceptions amongst those travelling to visit friends and relatives overseas
In a recent GSK survey of UK-based travellers to India and Pakistan, just 39% had sought travel health advice from their GP or travel clinic before their last trip, with 38% citing the fact that they were staying with friends and relatives as the main reason why they did not consider the need to do so. Over half (53%) of respondents admitted that they didn’t know how Hepatitis B is caught and over a third (39%) didn’t know how they could prevent themselves from contracting the disease.
As more than three million Muslims from around the World prepare to travel for Hajj pilgrimage in October , and with almost half of all UK visitors to India and Pakistan last year travelling with the purpose of visiting friends and relatives , the B-Aware campaign, launched this month by pharmaceutical company GlaxoSmithKline, and supported by the British Liver Trust, aims to educate these communities about the risk of Hepatitis B and ways to reduce their risk when travelling.
Andrew Langford, Chief Executive of the British Liver Trust says: “Hepatitis B is a serious and sometimes life-threatening disease which is 50 to 100 times more infectious than HIV. It is passed on to others from blood or body fluids of a person who has the virus, and not everyone who has the virus is ill or is aware that they could infect someone else. Even a tiny speck of dried blood from an infected person can be all it takes to pass on the virus. People visiting friends and relatives overseas, or traveling for pilgrimage, are urged to consider the risks and to seek travel health advice from their GP or travel clinic at least a month before travel.”
Those visiting friends and relatives overseas may perceive that they are not at risk of disease because they will be staying in familiar surroundings, however, in reality, these travellers tend to stay abroad for longer and live as part of the local community, and are therefore more likely to come across situations that could increase their likelihood of exposure to infectious diseases .
While contaminated medical equipment (especially needles) is a common way that the Hepatitis B virus is passed on, there are also many seemingly harmless ways that the infection can be spread such as sharing objects like razors, toothbrushes, nail clippers or earrings , , . B-Aware advises travellers not share personal or intimate belongings like these when visiting a country where Hepatitis B is more common than the UK, to avoid contact with blood or bodily fluids, to seek travel health advice before they go, and if possible, to carry a sterile medical kit.
Peter Basile, Medical Advisor at GSK says: “The B-Aware campaign will run across Indian and Pakistani media channels and information is distributed through local GP surgeries, pharmacies, travel agents and places of worship in 25 key regions of the UK, as well as at the London mela. The aim is to increase awareness and understanding of the risks of Hepatitis B when travelling and to encourage people to consider visiting their GP or travel clinic for health advice prior to travel.”
A campaign website www.b-aware.co.uk and mobile phone app have also been developed to offer further support to travellers with a risk indicator tool that enables them to check out their travel risk.
-ENDS-
Notes to editors:
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.
About the B-Aware campaign
B-Aware is a disease awareness campaign with the aim of providing information, promoting awareness and educating the public about Hepatitis B and its risk to health. The campaign is aimed at UK travellers who are travelling overseas to visit friends and relatives. In 2013, the campaign particularly focuses on those visiting friends and relatives in India and Pakistan, where the risk of Hepatitis B is greater than in the UK.
As part of the ‘B-Aware’ Campaign, communities will see health messages through Indian and Pakistani television and radio channels, as well as in GP surgeries, pharmacies, travel agents and their local places of worship across 25 locations in the UK.
Travellers can visit www.b-aware.co.uk for more information and to check out their travel risk.
For further information, please contact:
Helena Wright
Email: Helena.l.wright@gsk.com Tel: 0208 990 3601
Ruzanna Martirosyan
Email: ruzanna@mediareach.co.uk Tel: +44 (0) 2077513333
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.
Helena Wright
Email: Helena.l.wright@gsk.com Tel: 0208 990 3601
Mediareach Advertising Ltd
Ruzanna Martirosyan
PR Manager
T: +44 (0)20 77513333
F: +44 (0)20 77513334
E: Ruzanna@mediareach.co.uk
1 FBX | The Boulevard | Imperial Wharf |
Imperial Road | London SW6 2TL
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release B-Aware to prevent good times turning bad here
News-ID: 270392 • Views: …
More Releases from GlaxoSmithKline

GSK-Consumer Healthcare Organizes Symposium Tour on Smoking Cessation
Dubai, United Arab Emirates, December 6, 2011: - GSK- Consumer Healthcare has organized a Symposium Tour for the region’s Healthcare Professionals (HCPs) on the subject of ‘Smoking Cessation with Therapeutic Nicotine’. The tour includes 5 sessions for HCPs across Abu Dhabi, Dubai, Beirut, Riyadh & Jeddah between December 6th and 12th 2011.
Dr. Saul Shiffman has been invited to conduct these series of lectures.
Dr. Shiffman – PhD, currently holds…
More Releases for Hepatitis
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Key Influencer in the Hepatitis B Virus (HBV) Market 2025: Rising Hepatitis B In …
Which drivers are expected to have the greatest impact on the over the hepatitis b virus (hbv) market's growth?
The escalated incidence rates of hepatitis B infection are anticipated to contribute significantly to the future expansion of the hepatitis B virus market. Hepatitis B is a liver-related infection that is triggered by the hepatitis B virus (HBV), and can be avoided through vaccination. The surge in hepatitis B infection rates could…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962
This latest report researches the industry structure,…